JPH0531544B2 - - Google Patents
Info
- Publication number
- JPH0531544B2 JPH0531544B2 JP57192622A JP19262282A JPH0531544B2 JP H0531544 B2 JPH0531544 B2 JP H0531544B2 JP 57192622 A JP57192622 A JP 57192622A JP 19262282 A JP19262282 A JP 19262282A JP H0531544 B2 JPH0531544 B2 JP H0531544B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- cis
- azabicyclo
- octane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000001875 compounds Chemical class 0.000 claims description 41
- 125000004432 carbon atom Chemical group C* 0.000 claims description 18
- 150000003839 salts Chemical class 0.000 claims description 15
- 229910052799 carbon Inorganic materials 0.000 claims description 7
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical group C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 claims description 6
- 125000002619 bicyclic group Chemical group 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 2
- 239000000203 mixture Substances 0.000 description 14
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 11
- 241000700159 Rattus Species 0.000 description 7
- -1 glyoxylic acid ester Chemical class 0.000 description 7
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 229910052717 sulfur Inorganic materials 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 238000001990 intravenous administration Methods 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 150000002168 ethanoic acid esters Chemical class 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 108010064733 Angiotensins Proteins 0.000 description 2
- 102000015427 Angiotensins Human genes 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 125000003710 aryl alkyl group Chemical group 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000007327 hydrogenolysis reaction Methods 0.000 description 2
- 230000001631 hypertensive effect Effects 0.000 description 2
- 230000001077 hypotensive effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OQHKEWIEKYQINX-UHFFFAOYSA-N 1,2,3,3a,4,5,6,6a-octahydrocyclopenta[b]pyrrol-1-ium-2-carboxylate Chemical class C1CCC2NC(C(=O)O)CC21 OQHKEWIEKYQINX-UHFFFAOYSA-N 0.000 description 1
- ADFXKUOMJKEIND-UHFFFAOYSA-N 1,3-dicyclohexylurea Chemical compound C1CCCCC1NC(=O)NC1CCCCC1 ADFXKUOMJKEIND-UHFFFAOYSA-N 0.000 description 1
- KOFSFYBXUYHNJL-UHFFFAOYSA-N 1-(cyclopenten-1-yl)pyrrolidine Chemical compound C1CCCN1C1=CCCC1 KOFSFYBXUYHNJL-UHFFFAOYSA-N 0.000 description 1
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 1
- VAPOFMGACKUWCI-UHFFFAOYSA-N 4-(cyclopenten-1-yl)morpholine Chemical compound C1CCC=C1N1CCOCC1 VAPOFMGACKUWCI-UHFFFAOYSA-N 0.000 description 1
- ZPLCXHWYPWVJDL-UHFFFAOYSA-N 4-[(4-hydroxyphenyl)methyl]-1,3-oxazolidin-2-one Chemical compound C1=CC(O)=CC=C1CC1NC(=O)OC1 ZPLCXHWYPWVJDL-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102100030988 Angiotensin-converting enzyme Human genes 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical class OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- HHLFWLYXYJOTON-UHFFFAOYSA-N Glyoxylic acid Natural products OC(=O)C=O HHLFWLYXYJOTON-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical group CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 1
- 150000008534 L-alanines Chemical class 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 238000006845 Michael addition reaction Methods 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium on carbon Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 235000002597 Solanum melongena Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001294 alanine derivatives Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001447 alkali salts Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 125000003435 aroyl group Chemical group 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000001589 carboacyl group Chemical group 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000013375 chromatographic separation Methods 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- BGTOWKSIORTVQH-UHFFFAOYSA-N cyclo-pentanone Natural products O=C1CCCC1 BGTOWKSIORTVQH-UHFFFAOYSA-N 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 239000003701 inert diluent Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000011777 magnesium Chemical class 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000014380 magnesium carbonate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical class OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- XUKJQVOYXYEVSK-UHFFFAOYSA-N methyl 2-acetamido-3-(2-oxocyclopentyl)propanoate Chemical compound COC(=O)C(NC(C)=O)CC1CCCC1=O XUKJQVOYXYEVSK-UHFFFAOYSA-N 0.000 description 1
- GIENHCGYXUYZFO-UHFFFAOYSA-N methyl 2-amino-2-(chloromethyl)-3-oxobutanoate Chemical compound COC(C(CCl)(C(C)=O)N)=O GIENHCGYXUYZFO-UHFFFAOYSA-N 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- SSOLNOMRVKKSON-UHFFFAOYSA-N proguanil Chemical compound CC(C)\N=C(/N)N=C(N)NC1=CC=C(Cl)C=C1 SSOLNOMRVKKSON-UHFFFAOYSA-N 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000008925 spontaneous activity Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000563 toxic property Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Chemical class OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005550 wet granulation Methods 0.000 description 1
- 238000010626 work up procedure Methods 0.000 description 1
- 239000011701 zinc Chemical class 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
æ¬çºæã¯ãåŒ
ãæããã·ã¹ããšã³ãã¢ã¶ãã·ã¯ãã3.3.0ããª
ã¯ã¿ã³ã«ã«ãã³é žã®èªå°äœãªãã³ã«ãã®ççåŠç
ã«èš±å®¹ãããå¡©ã«é¢ãããããã§äžèšåŒäžãæ©é
ïŒbridgeâheadïŒççŽ ååïŒããã³ïŒã®ãšããã«
ããæ°ŽçŽ ååã¯çžäºã«ã·ã¹é 眮ã§ãããããŠççŽ
ååïŒã«ããã«ã«ããã·åºã¯äºç°ç³»ã«å¯ŸããŠå åŽ
ã«é åããŠããïŒããªãã¡ãâCO2Håºã¯ã·ã¯ã
ãã³ã¿ã³ç°ã«é¢ããŠããïŒãéã®æå°ïŒïŒïŒã§æš
èãããççŽ ååããã³äºç°ç³»ã®ççŽ ååïŒã«ã
ãããã©ãªãã€ãŒäžå¿ã¯åã é 眮ã§ãããR2
ã¯æ°ŽçŽ ãã¡ãã«åºãŸãã¯ãšãã«åºãæå³ããã ççåŠçã«èš±å®¹ãããå¡©ãšããŠã¯ç¹ã«å¡©é žå¡©ã
ãã¬ã€ã³é žå¡©ãé ç³é žå¡©ãŸãã¯ã¢ã«ã«ãªå¡©ãCa
å¡©ãMgå¡©ããã³Znå¡©ããããããã æ¬çºæã¯ããã«åèšåŒãæããååç©ãŸãã¯
ãã®ççåŠçã«èš±å®¹ãããå¡©ã®è£œæ³ã«ãããŠã åŒ ïŒåŒäžéã®æå°ïŒïŒïŒã§æšèãããççŽ ååã«ã
ãããã©ãªãã€ãŒäžå¿ã¯åã é 眮ã§ããã
R2â²ã¯ã¡ãã«åºãŸãã¯ãšãã«åºãæå³ããïŒ ãæããååç©ãåŒïœãæããååç©ãŸãã¯åŒ
ïœãæããååç©ãšåŒïœãæããååç©ãšã®
ã©ã»ãæ··åç©
ã¯ã¿ã³ã«ã«ãã³é žã®èªå°äœãªãã³ã«ãã®ççåŠç
ã«èš±å®¹ãããå¡©ã«é¢ãããããã§äžèšåŒäžãæ©é
ïŒbridgeâheadïŒççŽ ååïŒããã³ïŒã®ãšããã«
ããæ°ŽçŽ ååã¯çžäºã«ã·ã¹é 眮ã§ãããããŠççŽ
ååïŒã«ããã«ã«ããã·åºã¯äºç°ç³»ã«å¯ŸããŠå åŽ
ã«é åããŠããïŒããªãã¡ãâCO2Håºã¯ã·ã¯ã
ãã³ã¿ã³ç°ã«é¢ããŠããïŒãéã®æå°ïŒïŒïŒã§æš
èãããççŽ ååããã³äºç°ç³»ã®ççŽ ååïŒã«ã
ãããã©ãªãã€ãŒäžå¿ã¯åã é 眮ã§ãããR2
ã¯æ°ŽçŽ ãã¡ãã«åºãŸãã¯ãšãã«åºãæå³ããã ççåŠçã«èš±å®¹ãããå¡©ãšããŠã¯ç¹ã«å¡©é žå¡©ã
ãã¬ã€ã³é žå¡©ãé ç³é žå¡©ãŸãã¯ã¢ã«ã«ãªå¡©ãCa
å¡©ãMgå¡©ããã³Znå¡©ããããããã æ¬çºæã¯ããã«åèšåŒãæããååç©ãŸãã¯
ãã®ççåŠçã«èš±å®¹ãããå¡©ã®è£œæ³ã«ãããŠã åŒ ïŒåŒäžéã®æå°ïŒïŒïŒã§æšèãããççŽ ååã«ã
ãããã©ãªãã€ãŒäžå¿ã¯åã é 眮ã§ããã
R2â²ã¯ã¡ãã«åºãŸãã¯ãšãã«åºãæå³ããïŒ ãæããååç©ãåŒïœãæããååç©ãŸãã¯åŒ
ïœãæããååç©ãšåŒïœãæããååç©ãšã®
ã©ã»ãæ··åç©
ãšåå¿ãããçæç©ãæ°ŽçŽ æ·»å ããããã³ïŒãŸã
ã¯ïŒé žãããã¯å¡©åºã§åŠçãããããŠåèšã©ã»ã
æ··åç©ã䜿çšããå Žåã¯ãé©åœãªæ®µéã§ãžã¢ã¹ã
ã¬ãªããŒæ··åç©ãåå²ãããããŠå Žåã«ããåŸã
ããåŒãæããååç©ããã®ççåŠçã«èš±å®¹ã
ããå¡©ã«å€æããããšãç¹åŸŽãšããåŒã®ååç©
ã®è£œæ³ã«ãé¢ããã äžèšååç©ã®è£œæ³ã«ãããŠãåŒã®ååç©ãš
åŒïœã®ååç©ãŸãã¯åŒïœãšïœã®ã©ã»ãæ··å
ç©ãšãåå¿ããããŠåŸãããçæç©ã¯ãæ°ŽçŽ æ·»å
å·¥çšãšé žãããã¯å¡©åºã«ããåŠçå·¥çšã®ãããã
äžæ¹åã¯äž¡æ¹ã®å·¥çšã«ãããã®ã¿ãé¢è±ããå
åç©ããããã¯ïŒ·ãšR2â²ã®äž¡è ãé¢è±ããååç©
ã«å€æãããŠåŒã®ååç©ãšãªãã æ¬çºæã¯ããã«åèšåŒãæããååç©ãŸãã¯
ãã®ççåŠçã«èš±å®¹ãããå¡©ãšè£œè¬çã«èš±å®¹ãã
ãæ äœãããªãé«è¡å§çæ²»ççšçµæç©ã«ãé¢ã
ãã R2â²ãã¡ãã«ãŸãã¯ãšã€ã«ã§ããåŒã®ååç©
ã¯ç¥ãããŠããïŒäŸãã¯ãšãŒãããç¹èš±ç¬¬
0037231å·æ现æžïŒãããŠçš®ã ã®åŸè·¯ã§å ¥æãã
ãã ããã«ãäžèšåŒïœã®ã¢ã»ãããšãã³ãã°ãªãª
ãã·ã«é žãšã¹ãã«ããã³ã¢ã©ãã³ãšã¹ãã«ãšãã³
ãããåå¿ããããšåŒã®ååç©ãçããããšã
ç¥ãããŠããã åŒã«ãããŠWâ²ã¯æ°ŽçŽ æ·»å å解ãå¡©åºå解ãŸã
ã¯é žå解ã«ããé¢è±ãããåºãæå³ãã奜ãŸãã
ã¯ãã³ãžã«ãŸãã¯ç¬¬ïŒããã«ã§ãããR2â²ã¯åèš
å®çŸ©ã®ãšããã§ããããã®ååç©ãPdãçšããŠ
æ°ŽçŽ å å解ãããšåŒã®ååç©ãçããã åŒã®ååç©ã¯åããçžåœããã±ãâã¢ã¯ãªã«
é žãšã¹ãã«ã«ã¢ã©ãã³ãšã¹ãã«ãçšããŠãã«ãšã«
ä»å ãããããšã«ããé«åéã§ååŸããããã ãšã¹ãã«å解ããããšãã³ãããåå¿ã®å Žåãšå
ãçæç©ãçããã 奜ãŸããïŒïŒ³âé 眮ãæãããžã¢ã¹ãã¬ãªã
ãŒã¯ïŒ¬âã¢ã©ãã³ãšã¹ãã«ãçšããå Žåã«åªå¢ãª
éã§çããããŠåŒã®ãšã¹ãã«ãçµæ¶åãããã
ãŸãã¯ã·ãªã«ã²ã«ã§ã¯ãããã°ã©ãåé¢ããããš
ã«ããååŸããããã ããã«ãåŒïœãŸãã¯ïœãæããã·ã¹ããšã³
ãâïŒâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³âïŒâ
ã«ã«ãã³é žãšã¹ãã«ãåŒ ãåŒäžX1ã¯ïŒã10åã®ççŽ ååãæãããžã¢ã«
ãã«ã¢ããã§ããããŸãã¯åŒ ïŒããã§ïœããã³ïœã¯ïŒãïŒã®æŽæ°ãè¡šããã
ïŒïœïŒïœïŒãïŒã§ãããããŠïŒ¡ã¯CH2ãNHã
ãŸãã¯ïŒ³ãæå³ããïŒãæããåºãè¡šããããæ
ããã·ã¯ããã³ã¿ãã³ã®ãšããã³ãåŒ ïŒåŒäžX2ã¯æ±æ žæ§åºå¥œãŸããã¯å¡©çŽ ãŸãã¯èçŽ
ã§ãããY1ã¯ïŒãïŒã®ççŽ ååãæããã¢ã«ã«
ãã€ã«ãïŒãïŒåã®ççŽ ååãæããã¢ãã€ã«ãŸ
ãã¯ãã®ä»ã®ããããååŠã«æ £çšã®é žå解ããã
ä¿è·åºãè¡šããããããŠR3ã¯ïŒãïŒåã®ççŽ å
åãæããã¢ã«ãã«ãŸãã¯ïŒãïŒåã®ççŽ ååã
æããã¢ã©ã«ãã«ãè¡šããïŒãæããâã¢ã·ã«
åβâããã²ã³âαâã¢ããâã«ã«ãã³é žãšã¹ã
ã«ãŸãã¯åŒ ïŒåŒäžY1ããã³R3ã¯åèšããæå³ãæããïŒã
æããã¢ã«ãªã«é žãšã¹ãã«ãšåå¿ãããŠåŒ ïŒåŒäžR3ããã³Y1ã¯åèšããæå³ãæããïŒã
æããååç©ãšãªãããããåŒ·é žãçšããŠã¢ã·ã«
ã¢ããããã³ãšã¹ãã«ãå解ãããŠç°åãããŠåŒ
XIïœãŸãã¯XIïœ ãæããååç©ãšãªãããããé·ç§»éå±è§Šåªã®å
åšäžã«æ¥è§Šæ°ŽçŽ æ·»å ããããŸãã¯äœçŽã¢ã«ã³ãŒã«
äžãã©ã³âã¢ãã³è€åç©ãŸãã¯è€åç¡Œæ°ŽçŽ åç©ã
çšããŠéå ããããšã«ããåŒïœãŸãã¯ïœïŒåŒ
äžïŒ·ã¯æ°ŽçŽ ãè¡šããïŒãæããååç©ã«å€æãã
ããŠå Žåã«ãããšã¹ãã«åããŠåŒïœãŸãã¯ïœ
ïŒåŒäžïŒ·ã¯ïŒãïŒåã®ççŽ ååãæããã¢ã«ãã«
ãŸãã¯ïŒãïŒåã®ççŽ ååãæããã¢ã©ã«ãã«ã
è¡šããïŒãæããååç©ãšãªãããšã«ããå ¥æã
ããããšãèŠåºãããã åŒïœãŸãã¯ïœã®äºç°åŒã¢ããé žã¯ã·ã¹ããš
ã³ãé 眮ãæããŠãããããªãã¡âCO2Wåºãã·
ã¯ããã³ã¿ã³ç°ã®æ¹ã«åããŠãããä»ã®æ¬çºæäž
ã«ãããŠæ瀺ããããã¹ãŠã®ïŒâã¢ã¶ãã·ã¯ã
ã3.3.0ããªã¯ã¿ã³âïŒâã«ã«ãã³é žèªå°äœãã·
ã¹ããšã³ãé 眮ã§ååšããã 奜ãŸãããšããã³ã¯äŸãã°ãããªãžãã·ã¯ãã
ã³ãã³ããã³ã¢ã«ããªãã·ã¯ããã³ãã³ã§ããã
åŒã®ã¢ã«ãã«åçæç©ã®ç°åã¯å¥œãŸããã¯å¡©é ž
氎溶液ãçšããŠéè¡ããããåŒïŒïŒ·ïŒïŒšïŒã®å
åç©ã¯ã¢ããé žã«æ £çšã®æ¹æ³ãäŸãã°Houbenâ
Wey1æ°ç·šãMethoden der organischen
Chemieã第巻ïŒ1952幎ïŒåç §ãã«ããäŸãã°
å¡©åããªãã«ïŒãã³ãžã«ã¢ã«ã³ãŒã«ãŸãã¯ã€ãœã
ãã¬ã³ïŒç¡«é žãçšããŠãšã¹ãã«åããããããã
ã¯çžåœããåŸåŠçã«ããéé¢å¡©åºãŸãã¯å¡©ã®åœ¢æ
ãããåŒã®ååç©ãçããã åŒã®æ°èŠãªååç©ã¯é·ææç¶æ§ã®åŒ·ãè¡å§é
äžäœçšãæããããããã¯ã¢ã³ã®ãªãã³ã·ã³å€æ
é µçŽ ã®åŒ·åãªæå¶å€ïŒACEæå¶å€ïŒã§ãããã
ãŠçš®ã ã®èµ·æºã«ããé«è¡å§ã®æ²»çã«äœ¿çšããã
ãããã®ä»ã®è¡å§éäžãè¡ç®¡æ¡åŒµãŸãã¯å©å°¿äœçš
æ§ååç©ãšããããçµåããããšãå¯èœã§ããã
ãããäœçšçš®é¡ã®ä»£è¡šç©ã¯äŸãã°Erhardtâ
Ruschigäž¡æ°ã«ãããArzneimittelã第ïŒç
ïŒ1972幎ïŒã«èšèŒãããŠããã䜿çšã¯éèãç®äž
ãŸãã¯çµå£ã«ããéè¡ããããã çµå£æäžã«ãããæè¬éã¯ïŒåïŒã100mgã§ã
ãããããŸã§ææ¯ãªæ§è³ªã¯èŠ³å¯ãããŠããªããã
éçã®å Žåã«ã¯å¢éããããããã®éãæžããã
ãšãå¯èœã§ããšã«å©å°¿å€ãåæã«æäžãããå Žå
ã«ãšãããé©åã§ããã æ¬çºæã«ããååç©ã¯çžåœããè¬åŠç補å€ã®åœ¢
ã§çµå£ãŸãã¯éçµå£çã«æäžãããããçµå£äœ¿çš
圢æ ã«ã¯ã掻æ§ååç©ãããã«æ £çšã®æ·»å ç©è³ªäŸ
ãã°æ äœãå®å®å€ãŸãã¯äžæŽ»æ§åžéå€ãšæ··åãã
ããŠåžžæ³ã«ããé©åœãªæè¬åœ¢æ ãäŸãã°é å€ãç³
è¡£å€ãæ£ç¶ã«ãã»ã«ãæ°Žæ§ãã¢ã«ã³ãŒã«æ§ããã
ã¯æ²¹æ§æº¶æ¶²ãŸãã¯æ°Žæ§ãã¢ã«ã³ãŒã«æ§ãããã¯æ²¹
æ§æžæ¿æ¶²ãšãªããäžæŽ»æ§æ äœãšããŠã¯äŸãã°ã¢ã©
ãã¢ãŽã ãçé žãã°ãã·ãŠã ãçé žã«ãªãŠã ãä¹³
ç³ãã°ã«ã³ãŒã¹ãŸãã¯æŸ±ç²ç¹ã«ãšããããã柱ç²
ã䜿çšããããããã®é調補ã¯ä¹ŸåŒé¡ç²ãŸãã¯æ¹¿
åŒé¡ç²ãšããŠéè¡ãããããæ²¹æ§æ äœç©è³ªãŸãã¯
溶åªãšããŠã¯äŸãã°ããã¯ãªæ²¹ãŸãã¯èæ²¹ã®ãã
ãªæ€ç©æ§ããã³åç©æ§ã®æ²¹ããããããã ç®äžãŸãã¯éèãžã®æäžã«ã¯æŽ»æ§ååç©ãŸãã¯
ãã®ççåŠçã«å容ãããå¡©ãææã®å Žåã¯ãã
ã«æ £çšã®ç©è³ªäŸãã°æº¶è§£è£å©å€ãä¹³åå€ãŸãã¯ã
ã®ä»ã®å©å€ãçšããŠæº¶æ¶²ãæžæ¿æ¶²ãŸãã¯ä¹³æ¿æ¶²ãš
ãªããæ°èŠãªæŽ»æ§ååç©ããã³çžåœããççåŠç
ã«å容ãããå¡©ã«å¯Ÿãã溶åªãšããŠãããããã
ã®ã¯äŸãã°ãæ°Žãççé£å¡©æº¶æ¶²ãŸãã¯ã¢ã«ã³ãŒã«
ïŒäŸãã°ãšã¿ããŒã«ããããã³ãžãªãŒã«ãŸãã¯ã°
ãªã»ãªã³ïŒããããã®ä»ç³æº¶æ¶²äŸãã°ã°ã«ã³ãŒã¹
ãŸãã¯ãã³ããã溶液ãããã¯ãŸãäžèšããçš®ã
ã®æº¶åªã®æ··åç©ã§ããã çµå£æäžã«ãããŠãéåžžã«åŒ·ãåŒã®ååç©ã®
å¹åãäžèšè¬çåŠçããŒã¿ã«ãã蚌æããã ïŒ éº»é ãããã©ãããžã®éèå æäžïŒ310ngã®
ã¢ã³ã®ãªãã³ã·ã³ã«ããæ¹èµ·ãããè¡å§äº¢é²
åå¿ã®æäž30ååŸã«ããã50ïŒ æå¶âŠED50ïŒR2 ED50ïŒÎŒïœïŒKgïŒ C2H5 8.3  2.7 ïŒ éº»é ãããã©ãããžã®åäºæè žå æäžR2 ED50ïŒÎŒïœïŒKgïŒ C2H5 50  600 ïŒ èŠéããŠããã©ãããžã®çµå£æäžã«ãããŠäŸ
ãã°åŒïŒåŒäžR2ã¯ãšãã«ã§ããïŒã®ååç©
ã¯ã¢ã³ã®ãªãã³ã·ã³ã®éèæäžã«ããæ¹èµ·ã
ããè¡å§äº¢é²åå¿ã«å¯ŸãïŒmgïŒKgã®éã§ïŒæé
ã«ããã€ãŠæç¶ãã90ïŒ ä»¥äžã®æå¶ã瀺ãã ïŒ ã©ããã«ãããæ¥æ§æ¯æ§ åŒïŒåŒäžR2ã¯ãšãã«ã§ããïŒã®ååç©
10000mgïŒKgã®ïŒåçµå£æäžã¯ã©ãããæ»äº¡ã
ããªãã€ããå¯äžã®ç°åžžã¯èªçºç掻åãããã
ã«æžå°ããããšã§ãã€ããåæ€ã®æèŠã¯æ£åžžã§
ãã€ãã ãŸãäžèšååç©ã®éèå æäžã«ããLD50ã¯ã
éæ§ã©ããã§687.7mgïŒKgãéæ§ã©ãã608.7
mgïŒKgã§ãã€ãã æ¬çºææ¹æ³ãäžèšäŸã«ããããã«è©³çŽ°ã«èª¬æã
ãããæ¬çºæã¯ãããã«éå®ããããã®ã§ã¯ãª
ãã äŸ ïŒ ïŒâãâïŒïŒââã«ã«ããšããã·âïŒâããš
ãã«âãããã«ïŒââã¢ã©ãã«ãâïŒâã·ã¹ã
ãšã³ãâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³âïŒ
ââã«ã«ãã³é ž (1) ïŒâã¢ã»ãã«ã¢ããâïŒâïŒïŒâãªããœâã·
ã¯ããã³ãã«ïŒâããããªã³é žã¡ãã«ãšã¹ãã« ïŒâã¯ããâïŒâã¢ã»ãã«âã¢ããããããª
ã³é žã¡ãã«ãšã¹ãã«269ïœããã³ã·ã¯ããã³ã
ããããªãžã³257ïœãDMF1.5äž24æé宀枩
ã«ä¿æãããç空äžã«æ¿çž®ããæ®çç©ãå°éã®
æ°Žã«ãšããæ¿å¡©é žãçšããŠPHïŒã«èª¿è£œããããŠ
åïŒã®é ¢é žãšã¹ãã«ãçšããŠïŒåæœåºããã
ææ©çžãæ¿çž®ãããšæ·¡é»è²æ²¹ç¶ç©ãæ®çããã
åé290ïœ NMRïŒCDCl3ïŒïŒ2.02ïŒs.3HïŒ3.74ïŒïœïŒ3HïŒã
4.4ã4.8ïŒïœïŒ1HïŒ å çŽ åæå€ ïŒ£ïŒ ïŒšïŒ ïŒ®ïŒ èšç®å€ïŒ 58.1 7.54 6.16 å®æž¬å€ïŒ 58.5 7.2 6.5 (2) ã·ã¹ããšã³ãâïŒâã¢ã¶ãã·ã¯ãã3.3.0ã
ãªã¯ã¿ã³âïŒâã«ã«ãã³é žå¡©é žå¡© åèš(1)ã§èª¿è£œãããã¢ã»ãã«ã¢ããèªå°äœ
270ïœã2nå¡©é ž1.5äžã§45åééæµç ®æ²žããã
ç空äžã«æ¿çž®ããæ®çç©ãæ°·é ¢é žäžã«ãšãã
ptïŒïŒ£ïŒPt10ïŒ ïŒïŒïœãå ããããŠïŒããŒã«ã§
æ°ŽçŽ æ·»å ãããéåŸæ¿çž®ããããŠæ®çç©ãã¯
ãããã«ã ïŒãžã€ãœãããã«ãšãŒãã«ããçµæ¶
åããããèç¹205ã209âãåé150ïœã (3) ã·ã¹ããšã³ãâïŒâã¢ã¶ãã·ã¯ãã3.3.0ã
ãªã¯ã¿ã³âïŒâã«ã«ãã³é žãã³ãžã«ãšã¹ãã«å¡©
é žå¡© åèš(2)ã§èª¿è£œãããã«ã«ãã³é ž40ïœããã³ãž
ã«ã¢ã«ã³ãŒã«390ïœããã³å¡©åããªãã«65ïœã
ããªãæ°·å·ãããæ··åç©äžã«å ããŠãããŠ24æ
é宀枩ã«æŸçœ®ãããç空äžã«æ¿çž®åŸãã®ãã³ãž
ã«ãšã¹ãã«47ïœãã¯ãããã«ã ïŒã€ãœãããã
ãŒã«ããçµæ¶åãããèç¹175âïŒå¡©é žå¡©ïŒã (4) ïŒâãâïŒïŒââã«ã«ããšããã·âïŒâã
ãšãã«âãããã«ïŒââã¢ã©ãã«ãâã·ã¹ããš
ã³ãâïŒâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³â
ïŒââã«ã«ãã³é žãã³ãžã«ãšã¹ãã« åèš(3)ã§èª¿è£œããããã³ãžã«ãšã¹ãã«14ïœã
HOBt6.7ïœãâïŒïŒââã«ã«ããšããã·â
ïŒâããšãã«ãããã«ïŒââã¢ã©ãã³13.8ïœ
ããã³ãžã·ã¯ãããã·ã«ã«ã«ããžã€ãã10.2ïœ
ãšãžã¡ãã«ãã«ã ã¢ãã200mläžã§åå¿ãããã
宀枩ã§ïŒæéæ¹æåŸæåºãããžã·ã¯ãããã·ã«
å°¿çŽ ãåžåŒéããæ¿çž®ããé ¢é žãšã¹ãã«ïŒ
äžã«ãšããããŠïŒïŒ NaHCO3溶液500mlãã€ã
çšããŠïŒåæ¯çªæœåºãããææ©çžãæ¿çž®ããã
ãŠé ¢é žãšã¹ãã«ïŒç³æ²¹ãšãŒãã«ïŒïŒïŒïŒïŒãçš
ãã·ãªã«ã²ã«ïŒKgã®ã«ã©ã ã§ã¯ãããã°ã©ãã€
ãŒãããã¯ããã«æº¶åºããç°æ§äœã¯ïŒ³ïŒïŒ³ïŒïŒ³
âååç©ã§ãããåŸããã®æº¶åºæ¶²ãæ¿çž®ãããš
ïŒïŒ³ïŒïŒ²âååç©ãåŸããããããããçæ
ç©8.0ïœãæ²¹ç¶ç©ãšããŠåŸãããã NMRïŒCDCl3ïŒïŒïŒ³ïŒïŒ³ïŒïŒ³âååç©ãç¹åŸŽç
ãªã·ã°ãã«ïŒ1.20ïŒïœïŒ3HïŒã1.27ïŒïœïŒ2HïŒã
4.17ïŒïœïŒ3HïŒã5.13ïŒïœïŒ2HïŒã7.18ïŒïœïŒ
5HïŒã7.32ïŒïœïŒ5HïŒã å çŽ åæå€ïŒC30H38N2O5ãšããŠïŒ ïŒ£ïŒ ïŒšïŒ ïŒ®ïŒ èšç®å€ïŒ 71.1 7.56 5.53 å®æž¬å€ïŒ 70.8 7.8 5.7 (5) ïŒâãâïŒïŒââã«ã«ããšããã·âïŒâã
ãšãã«âãããã«ïŒââã¢ã©ãã«ãâã·ã¹ããš
ã³ãâïŒâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³â
ïŒââã«ã«ãã³é ž åèš(4)ã§åŸãããïŒïŒ¬ïŒïŒ¬âãã³ãžã«ãšã¹
ãã«8.0ïœããšã¿ããŒã«100mläžã«æº¶è§£ãããã
ãŠ10ïŒ PdïŒC0.5ïœãæ·»å ããŠåžžå§äžã«æ°ŽçŽ æ·»
å å解çã«è±ããžã«ããããã®åå¿ã¯å å§äžã«
ãã€åå¿æéãççž®ããŠè¡ãããšãã§ãããèš
ç®éã®æ°ŽçŽ ãåžåãããåŸè§Šåªãå»ããããŠ
ç空äžã«æ¿çž®ãããåæ§ã€ãªã³ãã»ãšãã©å®é
çåçã§ãšãŒãã«ããæ¶åºãããèç¹110ã112
âïŒå解ïŒã åœéã®å¡©é žãæ·»å ããããšã«ããå¡©é žå¡©
ïŒ120â以äžã§å解ïŒãåŸãããŸãã¯æšèšååç©
ã®æ¿ã¡ã¿ããŒã«æ§æº¶æ¶²äžã«æ°Žæ§äºéå¡©ãæ·»å ã
ãããšã«ããç±çã«ç¹ã«å®å®ãªZnâé¯å¡©ïŒ160
â以äžã§å解ïŒãåŸããããã å çŽ åæå€ïŒC23H32N2O5ãšããŠïŒ ïŒ£ïŒ ïŒšïŒ ïŒ®ïŒ èšç®å€ïŒ 66.3 7.7 6.73 å®ç§å€ïŒ 66.1 7.8 6.6 åŸãããNMRããã³ãã¹ã¯ãã¯ãã«ã¯æå®ã®
æ§é ãšäžèŽããããαãDïŒïŒ15.6ãïŒïœïŒïŒãã¡ã¿ã
ãŒã«ïŒã äŸ ïŒ åŒïŒR2ïŒïŒšïŒãæããååç©èª¿è£œã®ããã®
ãšã¹ãã«ã®ããåïŒäžè¬åŒïŒ çžåœããåŒã®ã¢ã«ãã«ãšã¹ãã«10ïœïŒåŒäžã®
R2ãã¢ã«ãã«ã®ååç©ïŒããžã¡ããã·ãšã¿ã³200
mläžã«æº¶è§£ããããããã«åžæ瀺è¬æº¶æ¶²äŸãã°ã
ãã ãã¢ãŒã«ãã«ãŒïŒæ»Žãå ããããŠåŒ·åã«æ¹æ
ããªããïŒåéã§åœéé é ã®4nKOHïŒæ°Žæ§ïŒã
ããã«å ãããšãæ瀺è¬ã¯åå¿çµäºããŠPHïŒã10
ã瀺ãã次ã«å¡©é žãçšããŠïŒPHã«èª¿è£œãç空äžã«
æ¿çž®ä¹Ÿåºããé ¢é žãšã¹ãã«250mläžã«ãšããããŠ
éãããé ¢é žãšã¹ãã«ãæ¿çž®ãããšãžã«ã«ãã³
é žãåºåœ¢çµæ¶ãŸãã¯ç¡å®åœ¢ååç©ãšããŠæ²æŸ±ã
ããåéã¯80ã95ïŒ ã§ããã äŸ ïŒ ïŒâãâïŒïŒââã«ã«ããã·âïŒâããšãã«
âãããã«ïŒââã¢ã©ãã«ãâã·ã¹ããšã³ãâïŒ
âã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³âïŒââã«
ã«ãã³é ž äŸïŒ(5)ã§åŸãããïŒâãâïŒïŒââã«ã«ããš
ããã·âïŒâããšãã«âãããã«ïŒââã¢ã©ã
ã«ãâã·ã¹ããšã³ãâïŒâã¢ã¶ãã·ã¯ãã3.3.0ã
ãªã¯ã¿ã³âïŒââã«ã«ãã³é žïŒïœãäŸïŒã«èšèŒ
ãããããã«ããŠããåïŒïŒæéïŒããããŠåŸåŠ
çãããåé0.85ïœãïœïŒïœ ïŒ388ã 補å€äŸ æ¬çºæçµæç©ã®çµå£æäžçšè£œå€ã®èª¿è£œ äžèšæåã䜿çšããŠãïŒâãâïŒïŒââã«ã«
ããšããã·âïŒâããšãã«ãããã«ïŒââã¢ã©
ãã«ãâïŒ1SïŒ3SïŒ5SïŒâïŒâã¢ã¶ãã·ã¯ã
ã3.3.0ããªã¯ã¿ã³âïŒâã«ã«ãã³é žãïŒé äž10mg
å«æããé å€1000é ã調補ããã ïŒâãâïŒïŒââã«ã«ããšããã·âïŒâããšã
ã«ãããã«ïŒââã¢ã©ãã«ãâïŒ1SïŒ3SïŒ5SïŒâ
ïŒâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³âïŒâã«ã«
ãã³é ž 10ïœ ã³ãŒã³ã¹ã¿ãŒã 140ïœ ãŒã©ãã³ 7.5ïœ åŸ®æ¶ã»ã«ããŒã¹ 2.5ïœ ã¹ãã¢ãªã³é žãã°ãã·ãŠã 2.5ïœ ïŒâãâïŒïŒââã«ã«ããšããã·âïŒâããš
ãã«ãããã«ïŒââã¢ã©ãã«ãâïŒ1SïŒ3SïŒ5SïŒ
âïŒâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³âïŒâã«
ã«ãã³é žããã³ã³ãŒã³ã¹ã¿ãŒãããŒã©ãã³æ°Žæº¶æ¶²
ãšæ··åããã該混åç©ã也ç¥ããé¡ç²ã«ç²ç ã
ãã埮æ¶ã»ã«ããŒã¹ããã³ã¹ãã¢ãªã³é žãã°ãã·
ãŠã ãäžèšé¡ç²ãšæ··åãããçæé¡ç²ãå§çž®ãã
é å€1000é ãã€ãããåé å€ã¯æå¹æå10mgãå«
æããã
ã¯ïŒé žãããã¯å¡©åºã§åŠçãããããŠåèšã©ã»ã
æ··åç©ã䜿çšããå Žåã¯ãé©åœãªæ®µéã§ãžã¢ã¹ã
ã¬ãªããŒæ··åç©ãåå²ãããããŠå Žåã«ããåŸã
ããåŒãæããååç©ããã®ççåŠçã«èš±å®¹ã
ããå¡©ã«å€æããããšãç¹åŸŽãšããåŒã®ååç©
ã®è£œæ³ã«ãé¢ããã äžèšååç©ã®è£œæ³ã«ãããŠãåŒã®ååç©ãš
åŒïœã®ååç©ãŸãã¯åŒïœãšïœã®ã©ã»ãæ··å
ç©ãšãåå¿ããããŠåŸãããçæç©ã¯ãæ°ŽçŽ æ·»å
å·¥çšãšé žãããã¯å¡©åºã«ããåŠçå·¥çšã®ãããã
äžæ¹åã¯äž¡æ¹ã®å·¥çšã«ãããã®ã¿ãé¢è±ããå
åç©ããããã¯ïŒ·ãšR2â²ã®äž¡è ãé¢è±ããååç©
ã«å€æãããŠåŒã®ååç©ãšãªãã æ¬çºæã¯ããã«åèšåŒãæããååç©ãŸãã¯
ãã®ççåŠçã«èš±å®¹ãããå¡©ãšè£œè¬çã«èš±å®¹ãã
ãæ äœãããªãé«è¡å§çæ²»ççšçµæç©ã«ãé¢ã
ãã R2â²ãã¡ãã«ãŸãã¯ãšã€ã«ã§ããåŒã®ååç©
ã¯ç¥ãããŠããïŒäŸãã¯ãšãŒãããç¹èš±ç¬¬
0037231å·æ现æžïŒãããŠçš®ã ã®åŸè·¯ã§å ¥æãã
ãã ããã«ãäžèšåŒïœã®ã¢ã»ãããšãã³ãã°ãªãª
ãã·ã«é žãšã¹ãã«ããã³ã¢ã©ãã³ãšã¹ãã«ãšãã³
ãããåå¿ããããšåŒã®ååç©ãçããããšã
ç¥ãããŠããã åŒã«ãããŠWâ²ã¯æ°ŽçŽ æ·»å å解ãå¡©åºå解ãŸã
ã¯é žå解ã«ããé¢è±ãããåºãæå³ãã奜ãŸãã
ã¯ãã³ãžã«ãŸãã¯ç¬¬ïŒããã«ã§ãããR2â²ã¯åèš
å®çŸ©ã®ãšããã§ããããã®ååç©ãPdãçšããŠ
æ°ŽçŽ å å解ãããšåŒã®ååç©ãçããã åŒã®ååç©ã¯åããçžåœããã±ãâã¢ã¯ãªã«
é žãšã¹ãã«ã«ã¢ã©ãã³ãšã¹ãã«ãçšããŠãã«ãšã«
ä»å ãããããšã«ããé«åéã§ååŸããããã ãšã¹ãã«å解ããããšãã³ãããåå¿ã®å Žåãšå
ãçæç©ãçããã 奜ãŸããïŒïŒ³âé 眮ãæãããžã¢ã¹ãã¬ãªã
ãŒã¯ïŒ¬âã¢ã©ãã³ãšã¹ãã«ãçšããå Žåã«åªå¢ãª
éã§çããããŠåŒã®ãšã¹ãã«ãçµæ¶åãããã
ãŸãã¯ã·ãªã«ã²ã«ã§ã¯ãããã°ã©ãåé¢ããããš
ã«ããååŸããããã ããã«ãåŒïœãŸãã¯ïœãæããã·ã¹ããšã³
ãâïŒâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³âïŒâ
ã«ã«ãã³é žãšã¹ãã«ãåŒ ãåŒäžX1ã¯ïŒã10åã®ççŽ ååãæãããžã¢ã«
ãã«ã¢ããã§ããããŸãã¯åŒ ïŒããã§ïœããã³ïœã¯ïŒãïŒã®æŽæ°ãè¡šããã
ïŒïœïŒïœïŒãïŒã§ãããããŠïŒ¡ã¯CH2ãNHã
ãŸãã¯ïŒ³ãæå³ããïŒãæããåºãè¡šããããæ
ããã·ã¯ããã³ã¿ãã³ã®ãšããã³ãåŒ ïŒåŒäžX2ã¯æ±æ žæ§åºå¥œãŸããã¯å¡©çŽ ãŸãã¯èçŽ
ã§ãããY1ã¯ïŒãïŒã®ççŽ ååãæããã¢ã«ã«
ãã€ã«ãïŒãïŒåã®ççŽ ååãæããã¢ãã€ã«ãŸ
ãã¯ãã®ä»ã®ããããååŠã«æ £çšã®é žå解ããã
ä¿è·åºãè¡šããããããŠR3ã¯ïŒãïŒåã®ççŽ å
åãæããã¢ã«ãã«ãŸãã¯ïŒãïŒåã®ççŽ ååã
æããã¢ã©ã«ãã«ãè¡šããïŒãæããâã¢ã·ã«
åβâããã²ã³âαâã¢ããâã«ã«ãã³é žãšã¹ã
ã«ãŸãã¯åŒ ïŒåŒäžY1ããã³R3ã¯åèšããæå³ãæããïŒã
æããã¢ã«ãªã«é žãšã¹ãã«ãšåå¿ãããŠåŒ ïŒåŒäžR3ããã³Y1ã¯åèšããæå³ãæããïŒã
æããååç©ãšãªãããããåŒ·é žãçšããŠã¢ã·ã«
ã¢ããããã³ãšã¹ãã«ãå解ãããŠç°åãããŠåŒ
XIïœãŸãã¯XIïœ ãæããååç©ãšãªãããããé·ç§»éå±è§Šåªã®å
åšäžã«æ¥è§Šæ°ŽçŽ æ·»å ããããŸãã¯äœçŽã¢ã«ã³ãŒã«
äžãã©ã³âã¢ãã³è€åç©ãŸãã¯è€åç¡Œæ°ŽçŽ åç©ã
çšããŠéå ããããšã«ããåŒïœãŸãã¯ïœïŒåŒ
äžïŒ·ã¯æ°ŽçŽ ãè¡šããïŒãæããååç©ã«å€æãã
ããŠå Žåã«ãããšã¹ãã«åããŠåŒïœãŸãã¯ïœ
ïŒåŒäžïŒ·ã¯ïŒãïŒåã®ççŽ ååãæããã¢ã«ãã«
ãŸãã¯ïŒãïŒåã®ççŽ ååãæããã¢ã©ã«ãã«ã
è¡šããïŒãæããååç©ãšãªãããšã«ããå ¥æã
ããããšãèŠåºãããã åŒïœãŸãã¯ïœã®äºç°åŒã¢ããé žã¯ã·ã¹ããš
ã³ãé 眮ãæããŠãããããªãã¡âCO2Wåºãã·
ã¯ããã³ã¿ã³ç°ã®æ¹ã«åããŠãããä»ã®æ¬çºæäž
ã«ãããŠæ瀺ããããã¹ãŠã®ïŒâã¢ã¶ãã·ã¯ã
ã3.3.0ããªã¯ã¿ã³âïŒâã«ã«ãã³é žèªå°äœãã·
ã¹ããšã³ãé 眮ã§ååšããã 奜ãŸãããšããã³ã¯äŸãã°ãããªãžãã·ã¯ãã
ã³ãã³ããã³ã¢ã«ããªãã·ã¯ããã³ãã³ã§ããã
åŒã®ã¢ã«ãã«åçæç©ã®ç°åã¯å¥œãŸããã¯å¡©é ž
氎溶液ãçšããŠéè¡ããããåŒïŒïŒ·ïŒïŒšïŒã®å
åç©ã¯ã¢ããé žã«æ £çšã®æ¹æ³ãäŸãã°Houbenâ
Wey1æ°ç·šãMethoden der organischen
Chemieã第巻ïŒ1952幎ïŒåç §ãã«ããäŸãã°
å¡©åããªãã«ïŒãã³ãžã«ã¢ã«ã³ãŒã«ãŸãã¯ã€ãœã
ãã¬ã³ïŒç¡«é žãçšããŠãšã¹ãã«åããããããã
ã¯çžåœããåŸåŠçã«ããéé¢å¡©åºãŸãã¯å¡©ã®åœ¢æ
ãããåŒã®ååç©ãçããã åŒã®æ°èŠãªååç©ã¯é·ææç¶æ§ã®åŒ·ãè¡å§é
äžäœçšãæããããããã¯ã¢ã³ã®ãªãã³ã·ã³å€æ
é µçŽ ã®åŒ·åãªæå¶å€ïŒACEæå¶å€ïŒã§ãããã
ãŠçš®ã ã®èµ·æºã«ããé«è¡å§ã®æ²»çã«äœ¿çšããã
ãããã®ä»ã®è¡å§éäžãè¡ç®¡æ¡åŒµãŸãã¯å©å°¿äœçš
æ§ååç©ãšããããçµåããããšãå¯èœã§ããã
ãããäœçšçš®é¡ã®ä»£è¡šç©ã¯äŸãã°Erhardtâ
Ruschigäž¡æ°ã«ãããArzneimittelã第ïŒç
ïŒ1972幎ïŒã«èšèŒãããŠããã䜿çšã¯éèãç®äž
ãŸãã¯çµå£ã«ããéè¡ããããã çµå£æäžã«ãããæè¬éã¯ïŒåïŒã100mgã§ã
ãããããŸã§ææ¯ãªæ§è³ªã¯èŠ³å¯ãããŠããªããã
éçã®å Žåã«ã¯å¢éããããããã®éãæžããã
ãšãå¯èœã§ããšã«å©å°¿å€ãåæã«æäžãããå Žå
ã«ãšãããé©åã§ããã æ¬çºæã«ããååç©ã¯çžåœããè¬åŠç補å€ã®åœ¢
ã§çµå£ãŸãã¯éçµå£çã«æäžãããããçµå£äœ¿çš
圢æ ã«ã¯ã掻æ§ååç©ãããã«æ £çšã®æ·»å ç©è³ªäŸ
ãã°æ äœãå®å®å€ãŸãã¯äžæŽ»æ§åžéå€ãšæ··åãã
ããŠåžžæ³ã«ããé©åœãªæè¬åœ¢æ ãäŸãã°é å€ãç³
è¡£å€ãæ£ç¶ã«ãã»ã«ãæ°Žæ§ãã¢ã«ã³ãŒã«æ§ããã
ã¯æ²¹æ§æº¶æ¶²ãŸãã¯æ°Žæ§ãã¢ã«ã³ãŒã«æ§ãããã¯æ²¹
æ§æžæ¿æ¶²ãšãªããäžæŽ»æ§æ äœãšããŠã¯äŸãã°ã¢ã©
ãã¢ãŽã ãçé žãã°ãã·ãŠã ãçé žã«ãªãŠã ãä¹³
ç³ãã°ã«ã³ãŒã¹ãŸãã¯æŸ±ç²ç¹ã«ãšããããã柱ç²
ã䜿çšããããããã®é調補ã¯ä¹ŸåŒé¡ç²ãŸãã¯æ¹¿
åŒé¡ç²ãšããŠéè¡ãããããæ²¹æ§æ äœç©è³ªãŸãã¯
溶åªãšããŠã¯äŸãã°ããã¯ãªæ²¹ãŸãã¯èæ²¹ã®ãã
ãªæ€ç©æ§ããã³åç©æ§ã®æ²¹ããããããã ç®äžãŸãã¯éèãžã®æäžã«ã¯æŽ»æ§ååç©ãŸãã¯
ãã®ççåŠçã«å容ãããå¡©ãææã®å Žåã¯ãã
ã«æ £çšã®ç©è³ªäŸãã°æº¶è§£è£å©å€ãä¹³åå€ãŸãã¯ã
ã®ä»ã®å©å€ãçšããŠæº¶æ¶²ãæžæ¿æ¶²ãŸãã¯ä¹³æ¿æ¶²ãš
ãªããæ°èŠãªæŽ»æ§ååç©ããã³çžåœããççåŠç
ã«å容ãããå¡©ã«å¯Ÿãã溶åªãšããŠãããããã
ã®ã¯äŸãã°ãæ°Žãççé£å¡©æº¶æ¶²ãŸãã¯ã¢ã«ã³ãŒã«
ïŒäŸãã°ãšã¿ããŒã«ããããã³ãžãªãŒã«ãŸãã¯ã°
ãªã»ãªã³ïŒããããã®ä»ç³æº¶æ¶²äŸãã°ã°ã«ã³ãŒã¹
ãŸãã¯ãã³ããã溶液ãããã¯ãŸãäžèšããçš®ã
ã®æº¶åªã®æ··åç©ã§ããã çµå£æäžã«ãããŠãéåžžã«åŒ·ãåŒã®ååç©ã®
å¹åãäžèšè¬çåŠçããŒã¿ã«ãã蚌æããã ïŒ éº»é ãããã©ãããžã®éèå æäžïŒ310ngã®
ã¢ã³ã®ãªãã³ã·ã³ã«ããæ¹èµ·ãããè¡å§äº¢é²
åå¿ã®æäž30ååŸã«ããã50ïŒ æå¶âŠED50ïŒR2 ED50ïŒÎŒïœïŒKgïŒ C2H5 8.3  2.7 ïŒ éº»é ãããã©ãããžã®åäºæè žå æäžR2 ED50ïŒÎŒïœïŒKgïŒ C2H5 50  600 ïŒ èŠéããŠããã©ãããžã®çµå£æäžã«ãããŠäŸ
ãã°åŒïŒåŒäžR2ã¯ãšãã«ã§ããïŒã®ååç©
ã¯ã¢ã³ã®ãªãã³ã·ã³ã®éèæäžã«ããæ¹èµ·ã
ããè¡å§äº¢é²åå¿ã«å¯ŸãïŒmgïŒKgã®éã§ïŒæé
ã«ããã€ãŠæç¶ãã90ïŒ ä»¥äžã®æå¶ã瀺ãã ïŒ ã©ããã«ãããæ¥æ§æ¯æ§ åŒïŒåŒäžR2ã¯ãšãã«ã§ããïŒã®ååç©
10000mgïŒKgã®ïŒåçµå£æäžã¯ã©ãããæ»äº¡ã
ããªãã€ããå¯äžã®ç°åžžã¯èªçºç掻åãããã
ã«æžå°ããããšã§ãã€ããåæ€ã®æèŠã¯æ£åžžã§
ãã€ãã ãŸãäžèšååç©ã®éèå æäžã«ããLD50ã¯ã
éæ§ã©ããã§687.7mgïŒKgãéæ§ã©ãã608.7
mgïŒKgã§ãã€ãã æ¬çºææ¹æ³ãäžèšäŸã«ããããã«è©³çŽ°ã«èª¬æã
ãããæ¬çºæã¯ãããã«éå®ããããã®ã§ã¯ãª
ãã äŸ ïŒ ïŒâãâïŒïŒââã«ã«ããšããã·âïŒâããš
ãã«âãããã«ïŒââã¢ã©ãã«ãâïŒâã·ã¹ã
ãšã³ãâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³âïŒ
ââã«ã«ãã³é ž (1) ïŒâã¢ã»ãã«ã¢ããâïŒâïŒïŒâãªããœâã·
ã¯ããã³ãã«ïŒâããããªã³é žã¡ãã«ãšã¹ãã« ïŒâã¯ããâïŒâã¢ã»ãã«âã¢ããããããª
ã³é žã¡ãã«ãšã¹ãã«269ïœããã³ã·ã¯ããã³ã
ããããªãžã³257ïœãDMF1.5äž24æé宀枩
ã«ä¿æãããç空äžã«æ¿çž®ããæ®çç©ãå°éã®
æ°Žã«ãšããæ¿å¡©é žãçšããŠPHïŒã«èª¿è£œããããŠ
åïŒã®é ¢é žãšã¹ãã«ãçšããŠïŒåæœåºããã
ææ©çžãæ¿çž®ãããšæ·¡é»è²æ²¹ç¶ç©ãæ®çããã
åé290ïœ NMRïŒCDCl3ïŒïŒ2.02ïŒs.3HïŒ3.74ïŒïœïŒ3HïŒã
4.4ã4.8ïŒïœïŒ1HïŒ å çŽ åæå€ ïŒ£ïŒ ïŒšïŒ ïŒ®ïŒ èšç®å€ïŒ 58.1 7.54 6.16 å®æž¬å€ïŒ 58.5 7.2 6.5 (2) ã·ã¹ããšã³ãâïŒâã¢ã¶ãã·ã¯ãã3.3.0ã
ãªã¯ã¿ã³âïŒâã«ã«ãã³é žå¡©é žå¡© åèš(1)ã§èª¿è£œãããã¢ã»ãã«ã¢ããèªå°äœ
270ïœã2nå¡©é ž1.5äžã§45åééæµç ®æ²žããã
ç空äžã«æ¿çž®ããæ®çç©ãæ°·é ¢é žäžã«ãšãã
ptïŒïŒ£ïŒPt10ïŒ ïŒïŒïœãå ããããŠïŒããŒã«ã§
æ°ŽçŽ æ·»å ãããéåŸæ¿çž®ããããŠæ®çç©ãã¯
ãããã«ã ïŒãžã€ãœãããã«ãšãŒãã«ããçµæ¶
åããããèç¹205ã209âãåé150ïœã (3) ã·ã¹ããšã³ãâïŒâã¢ã¶ãã·ã¯ãã3.3.0ã
ãªã¯ã¿ã³âïŒâã«ã«ãã³é žãã³ãžã«ãšã¹ãã«å¡©
é žå¡© åèš(2)ã§èª¿è£œãããã«ã«ãã³é ž40ïœããã³ãž
ã«ã¢ã«ã³ãŒã«390ïœããã³å¡©åããªãã«65ïœã
ããªãæ°·å·ãããæ··åç©äžã«å ããŠãããŠ24æ
é宀枩ã«æŸçœ®ãããç空äžã«æ¿çž®åŸãã®ãã³ãž
ã«ãšã¹ãã«47ïœãã¯ãããã«ã ïŒã€ãœãããã
ãŒã«ããçµæ¶åãããèç¹175âïŒå¡©é žå¡©ïŒã (4) ïŒâãâïŒïŒââã«ã«ããšããã·âïŒâã
ãšãã«âãããã«ïŒââã¢ã©ãã«ãâã·ã¹ããš
ã³ãâïŒâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³â
ïŒââã«ã«ãã³é žãã³ãžã«ãšã¹ãã« åèš(3)ã§èª¿è£œããããã³ãžã«ãšã¹ãã«14ïœã
HOBt6.7ïœãâïŒïŒââã«ã«ããšããã·â
ïŒâããšãã«ãããã«ïŒââã¢ã©ãã³13.8ïœ
ããã³ãžã·ã¯ãããã·ã«ã«ã«ããžã€ãã10.2ïœ
ãšãžã¡ãã«ãã«ã ã¢ãã200mläžã§åå¿ãããã
宀枩ã§ïŒæéæ¹æåŸæåºãããžã·ã¯ãããã·ã«
å°¿çŽ ãåžåŒéããæ¿çž®ããé ¢é žãšã¹ãã«ïŒ
äžã«ãšããããŠïŒïŒ NaHCO3溶液500mlãã€ã
çšããŠïŒåæ¯çªæœåºãããææ©çžãæ¿çž®ããã
ãŠé ¢é žãšã¹ãã«ïŒç³æ²¹ãšãŒãã«ïŒïŒïŒïŒïŒãçš
ãã·ãªã«ã²ã«ïŒKgã®ã«ã©ã ã§ã¯ãããã°ã©ãã€
ãŒãããã¯ããã«æº¶åºããç°æ§äœã¯ïŒ³ïŒïŒ³ïŒïŒ³
âååç©ã§ãããåŸããã®æº¶åºæ¶²ãæ¿çž®ãããš
ïŒïŒ³ïŒïŒ²âååç©ãåŸããããããããçæ
ç©8.0ïœãæ²¹ç¶ç©ãšããŠåŸãããã NMRïŒCDCl3ïŒïŒïŒ³ïŒïŒ³ïŒïŒ³âååç©ãç¹åŸŽç
ãªã·ã°ãã«ïŒ1.20ïŒïœïŒ3HïŒã1.27ïŒïœïŒ2HïŒã
4.17ïŒïœïŒ3HïŒã5.13ïŒïœïŒ2HïŒã7.18ïŒïœïŒ
5HïŒã7.32ïŒïœïŒ5HïŒã å çŽ åæå€ïŒC30H38N2O5ãšããŠïŒ ïŒ£ïŒ ïŒšïŒ ïŒ®ïŒ èšç®å€ïŒ 71.1 7.56 5.53 å®æž¬å€ïŒ 70.8 7.8 5.7 (5) ïŒâãâïŒïŒââã«ã«ããšããã·âïŒâã
ãšãã«âãããã«ïŒââã¢ã©ãã«ãâã·ã¹ããš
ã³ãâïŒâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³â
ïŒââã«ã«ãã³é ž åèš(4)ã§åŸãããïŒïŒ¬ïŒïŒ¬âãã³ãžã«ãšã¹
ãã«8.0ïœããšã¿ããŒã«100mläžã«æº¶è§£ãããã
ãŠ10ïŒ PdïŒC0.5ïœãæ·»å ããŠåžžå§äžã«æ°ŽçŽ æ·»
å å解çã«è±ããžã«ããããã®åå¿ã¯å å§äžã«
ãã€åå¿æéãççž®ããŠè¡ãããšãã§ãããèš
ç®éã®æ°ŽçŽ ãåžåãããåŸè§Šåªãå»ããããŠ
ç空äžã«æ¿çž®ãããåæ§ã€ãªã³ãã»ãšãã©å®é
çåçã§ãšãŒãã«ããæ¶åºãããèç¹110ã112
âïŒå解ïŒã åœéã®å¡©é žãæ·»å ããããšã«ããå¡©é žå¡©
ïŒ120â以äžã§å解ïŒãåŸãããŸãã¯æšèšååç©
ã®æ¿ã¡ã¿ããŒã«æ§æº¶æ¶²äžã«æ°Žæ§äºéå¡©ãæ·»å ã
ãããšã«ããç±çã«ç¹ã«å®å®ãªZnâé¯å¡©ïŒ160
â以äžã§å解ïŒãåŸããããã å çŽ åæå€ïŒC23H32N2O5ãšããŠïŒ ïŒ£ïŒ ïŒšïŒ ïŒ®ïŒ èšç®å€ïŒ 66.3 7.7 6.73 å®ç§å€ïŒ 66.1 7.8 6.6 åŸãããNMRããã³ãã¹ã¯ãã¯ãã«ã¯æå®ã®
æ§é ãšäžèŽããããαãDïŒïŒ15.6ãïŒïœïŒïŒãã¡ã¿ã
ãŒã«ïŒã äŸ ïŒ åŒïŒR2ïŒïŒšïŒãæããååç©èª¿è£œã®ããã®
ãšã¹ãã«ã®ããåïŒäžè¬åŒïŒ çžåœããåŒã®ã¢ã«ãã«ãšã¹ãã«10ïœïŒåŒäžã®
R2ãã¢ã«ãã«ã®ååç©ïŒããžã¡ããã·ãšã¿ã³200
mläžã«æº¶è§£ããããããã«åžæ瀺è¬æº¶æ¶²äŸãã°ã
ãã ãã¢ãŒã«ãã«ãŒïŒæ»Žãå ããããŠåŒ·åã«æ¹æ
ããªããïŒåéã§åœéé é ã®4nKOHïŒæ°Žæ§ïŒã
ããã«å ãããšãæ瀺è¬ã¯åå¿çµäºããŠPHïŒã10
ã瀺ãã次ã«å¡©é žãçšããŠïŒPHã«èª¿è£œãç空äžã«
æ¿çž®ä¹Ÿåºããé ¢é žãšã¹ãã«250mläžã«ãšããããŠ
éãããé ¢é žãšã¹ãã«ãæ¿çž®ãããšãžã«ã«ãã³
é žãåºåœ¢çµæ¶ãŸãã¯ç¡å®åœ¢ååç©ãšããŠæ²æŸ±ã
ããåéã¯80ã95ïŒ ã§ããã äŸ ïŒ ïŒâãâïŒïŒââã«ã«ããã·âïŒâããšãã«
âãããã«ïŒââã¢ã©ãã«ãâã·ã¹ããšã³ãâïŒ
âã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³âïŒââã«
ã«ãã³é ž äŸïŒ(5)ã§åŸãããïŒâãâïŒïŒââã«ã«ããš
ããã·âïŒâããšãã«âãããã«ïŒââã¢ã©ã
ã«ãâã·ã¹ããšã³ãâïŒâã¢ã¶ãã·ã¯ãã3.3.0ã
ãªã¯ã¿ã³âïŒââã«ã«ãã³é žïŒïœãäŸïŒã«èšèŒ
ãããããã«ããŠããåïŒïŒæéïŒããããŠåŸåŠ
çãããåé0.85ïœãïœïŒïœ ïŒ388ã 補å€äŸ æ¬çºæçµæç©ã®çµå£æäžçšè£œå€ã®èª¿è£œ äžèšæåã䜿çšããŠãïŒâãâïŒïŒââã«ã«
ããšããã·âïŒâããšãã«ãããã«ïŒââã¢ã©
ãã«ãâïŒ1SïŒ3SïŒ5SïŒâïŒâã¢ã¶ãã·ã¯ã
ã3.3.0ããªã¯ã¿ã³âïŒâã«ã«ãã³é žãïŒé äž10mg
å«æããé å€1000é ã調補ããã ïŒâãâïŒïŒââã«ã«ããšããã·âïŒâããšã
ã«ãããã«ïŒââã¢ã©ãã«ãâïŒ1SïŒ3SïŒ5SïŒâ
ïŒâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³âïŒâã«ã«
ãã³é ž 10ïœ ã³ãŒã³ã¹ã¿ãŒã 140ïœ ãŒã©ãã³ 7.5ïœ åŸ®æ¶ã»ã«ããŒã¹ 2.5ïœ ã¹ãã¢ãªã³é žãã°ãã·ãŠã 2.5ïœ ïŒâãâïŒïŒââã«ã«ããšããã·âïŒâããš
ãã«ãããã«ïŒââã¢ã©ãã«ãâïŒ1SïŒ3SïŒ5SïŒ
âïŒâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³âïŒâã«
ã«ãã³é žããã³ã³ãŒã³ã¹ã¿ãŒãããŒã©ãã³æ°Žæº¶æ¶²
ãšæ··åããã該混åç©ã也ç¥ããé¡ç²ã«ç²ç ã
ãã埮æ¶ã»ã«ããŒã¹ããã³ã¹ãã¢ãªã³é žãã°ãã·
ãŠã ãäžèšé¡ç²ãšæ··åãããçæé¡ç²ãå§çž®ãã
é å€1000é ãã€ãããåé å€ã¯æå¹æå10mgãå«
æããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ åŒ ãåŒäžæ©é ççŽ ååïŒããã³ïŒã®ãšããã«ããæ°Ž
çŽ ååã¯çžäºã«ã·ã¹é 眮ã§ããããããŠççŽ åå
ïŒã«ããã«ã«ããã·ã«åºã¯äºç°ç³»ã«å¯ŸããŠå åŽã«
é åããŠããïŒããªãã¡ãâCO2Håºã¯ã·ã¯ãã
ã³ã¿ã³ç°ã«é¢ããŠããïŒãéã®æå°ïŒïŒïŒã§æšè
ãããççŽ ååããã³äºç°ç³»ã®ççŽ ååïŒã«ãã
ããã©ãªãã€ãŒäžå¿ã¯åã é 眮ã§ãããR2ã¯
æ°ŽçŽ ãã¡ãã«åºãŸãã¯ãšãã«åºãæå³ããã ãæããååç©ãŸãã¯ãã®ççåŠçã«èš±å®¹ããã
å¡©ã ïŒ ïŒâãâïŒïŒââã«ã«ããšããã·âïŒâã
ãšãã«âãããã«ïŒââã¢ã©ãã«ãâã·ã¹ïŒãšã³
ãâïŒâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³âïŒâ
âã«ã«ãã³é žãŸãã¯ãã®ççåŠçã«èš±å®¹ããã
å¡©ã§ããåèšç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®åå
ç©ã ïŒ ïŒâãâïŒïŒââã«ã«ããã·âïŒâããšã
ã«âãããã«ïŒââã¢ã©ãã«ãâã·ã¹ïŒãšã³ãâ
ïŒâã¢ã¶ãã·ã¯ãã3.3.0ããªã¯ã¿ã³âïŒââ
ã«ã«ãã³é žãŸãã¯ãã®ççåŠçã«èš±å®¹ãããå¡©ã§
ããåèšç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®ååç©ã
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE31439462 | 1981-11-05 | ||
| DE3143946 | 1981-11-05 | ||
| DE32267681 | 1982-07-17 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1207997A Division JPH02104573A (ja) | 1981-11-05 | 1989-08-14 | ã·ã¹ïŒãšã³ãâïŒâã¢ã¶ãã·ã¯ããïŒïŒïŒïŒïŒããªã¯ã¿ã³âïŒâã«ã«ãã³é žèªå°äœã®è£œæ³ |
| JP1207998A Division JPH02104526A (ja) | 1981-11-05 | 1989-08-14 | é«è¡å§çæ²»ççšçµæç© |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58103364A JPS58103364A (ja) | 1983-06-20 |
| JPH0531544B2 true JPH0531544B2 (ja) | 1993-05-12 |
Family
ID=6145696
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP19262282A Granted JPS58103364A (ja) | 1981-11-05 | 1982-11-04 | ã·ã¹ïŒãšã³ãâïŒâã¢ã¶ãã·ã¯ããïŒïŒïŒïŒïŒããªã¯ã¿ã³âïŒâã«ã«ãã³é žèªå°äœ |
| JP61090187A Granted JPS6251A (ja) | 1981-11-05 | 1986-04-21 | ã·ã¹ïŒãšã³ãâïŒâã¢ã¶ãã·ã¯ããïŒïŒïŒïŒïŒããªã¯ã¿ã³âïŒâã«ã«ãã³é žèªå°äœããã³ãã®è£œæ³ |
| JP9018886A Granted JPS61293967A (ja) | 1981-11-05 | 1986-04-21 | ã·ã¹ïŒãšã³ãâïŒâã¢ã¶ãã·ã¯ããïŒïŒïŒïŒïŒããªã¯ã¿ã³âïŒâã«ã«ãã³é žèªå°äœããã³ãã®è£œæ³ |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61090187A Granted JPS6251A (ja) | 1981-11-05 | 1986-04-21 | ã·ã¹ïŒãšã³ãâïŒâã¢ã¶ãã·ã¯ããïŒïŒïŒïŒïŒããªã¯ã¿ã³âïŒâã«ã«ãã³é žèªå°äœããã³ãã®è£œæ³ |
| JP9018886A Granted JPS61293967A (ja) | 1981-11-05 | 1986-04-21 | ã·ã¹ïŒãšã³ãâïŒâã¢ã¶ãã·ã¯ããïŒïŒïŒïŒïŒããªã¯ã¿ã³âïŒâã«ã«ãã³é žèªå°äœããã³ãã®è£œæ³ |
Country Status (4)
| Country | Link |
|---|---|
| JP (3) | JPS58103364A (ja) |
| MX (1) | MX9217A (ja) |
| SU (1) | SU1327787A3 (ja) |
| ZA (1) | ZA828085B (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3324263A1 (de) * | 1983-07-06 | 1985-01-17 | Hoechst Ag, 6230 Frankfurt | Derivate der 2-azabicyclo(3.1.0)hexan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-azabicyclo(3.1.0)hexan-derivate als zwischenprodukte und verfahren zu deren herstellung |
| DE3333455A1 (de) * | 1983-09-16 | 1985-04-11 | Hoechst Ag, 6230 Frankfurt | Verfahren zur herstellung n-alkylierter dipeptide und deren estern |
| DE3413710A1 (de) * | 1984-04-12 | 1985-10-24 | Hoechst Ag, 6230 Frankfurt | Verfahren zur behandlung der herzinsuffizienz |
| US4925969A (en) * | 1985-02-04 | 1990-05-15 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Process for preparing ethyl-alpha-amino-gamma-oxo-gamma-phenybutyrate derivatives |
| DE3536687A1 (de) * | 1985-10-15 | 1987-04-16 | Hoechst Ag | Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit |
| DE3633496A1 (de) * | 1986-10-02 | 1988-04-14 | Hoechst Ag | Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln |
| JP2754010B2 (ja) * | 1988-05-23 | 1998-05-20 | æ ªåŒäŒç€Ÿãªã³ãŒ | ç»å圢æè£ çœ®ã«æŒããåæ æäœã®ã¯ãªãŒãã³ã°æ¹æ³ |
| US4947750A (en) * | 1988-08-19 | 1990-08-14 | Presstek, Inc. | Printing member for a press with dampening |
| JP3316639B2 (ja) * | 1993-03-05 | 2002-08-19 | ã³ãã«æ ªåŒäŒç€Ÿ | é«æ床ã§å®å®æ§ã®åªããããã²ã³åéåçæå ææ |
| JP3792777B2 (ja) * | 1996-05-10 | 2006-07-05 | æ ªåŒäŒç€Ÿã«ãã« | ïŒâã¢ã«ã³ãã·ã«ã«ããã«âïŒâãã§ãã«ãããã«èªå°äœã®è£œé æ¹æ³ |
| AR033048A1 (es) | 2001-03-19 | 2003-12-03 | Kaneka Corp | Metodo para la purificacion de la n-(1(s)-etoxicarbonil-3-fenilpropil) -l-alanina |
| CA2554199C (en) * | 2004-01-19 | 2013-07-02 | Lupin Limited | Process for crystallization of ramipril and preparation of a hydrated form thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5777672A (en) * | 1980-08-30 | 1982-05-15 | Hoechst Ag | Amino acid derivative and manufacture |
| JPS5791974A (en) * | 1980-10-02 | 1982-06-08 | Science Union & Cie | Imino diacid compound, manufacture and medicinal composition containing same as active component |
| JPS57112359A (en) * | 1980-10-23 | 1982-07-13 | Schering Plough Corp | Carboxylalkyl dipeptide, manufacture and medicinal composition |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH074338B2 (ja) * | 1987-02-27 | 1995-01-25 | ãªãªã³ãã¹å åŠå·¥æ¥æ ªåŒäŒç€Ÿ | å èŠé¡ |
-
1982
- 1982-11-03 SU SU823513217A patent/SU1327787A3/ru active
- 1982-11-04 JP JP19262282A patent/JPS58103364A/ja active Granted
- 1982-11-04 ZA ZA828085A patent/ZA828085B/xx unknown
-
1986
- 1986-04-21 JP JP61090187A patent/JPS6251A/ja active Granted
- 1986-04-21 JP JP9018886A patent/JPS61293967A/ja active Granted
-
1989
- 1989-01-05 MX MX921789A patent/MX9217A/es unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5777672A (en) * | 1980-08-30 | 1982-05-15 | Hoechst Ag | Amino acid derivative and manufacture |
| JPS5791974A (en) * | 1980-10-02 | 1982-06-08 | Science Union & Cie | Imino diacid compound, manufacture and medicinal composition containing same as active component |
| JPS57112359A (en) * | 1980-10-23 | 1982-07-13 | Schering Plough Corp | Carboxylalkyl dipeptide, manufacture and medicinal composition |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH047741B2 (ja) | 1992-02-12 |
| SU1327787A3 (ru) | 1987-07-30 |
| JPS6251A (ja) | 1987-01-06 |
| JPH0559105B2 (ja) | 1993-08-30 |
| MX9217A (es) | 1993-07-01 |
| ZA828085B (en) | 1983-09-28 |
| JPS58103364A (ja) | 1983-06-20 |
| JPS61293967A (ja) | 1986-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0355449B2 (ja) | ||
| KR910000234B1 (ko) | ìì€, ìë-2-ììë¹ì¬ìŽíŽë¡[5.3.0]ë°ì¹ž-3-칎복ì€ì° ì ë첎ì ì ì¡°ë°©ë² | |
| US4086338A (en) | N-carboxyalkanoyl derivatives of azetidine-2-carboxylic acid | |
| US4591598A (en) | Derivatives of 2-azabicyclo[3.1.0]hexane-3-carboxylic acid, and hypotensive use thereof | |
| EP0090341B1 (de) | Spiro(4.(3+n))-2-aza-alkan-3-carbonsÀure-Derivate, Verfahren zu ihrer Herstellung, diese enthaltende Mittel und ihre Verwendung | |
| US4562202A (en) | N-Acyl hexahydroindole-2-carboxylic acids and anti-hypertensive use thereof | |
| JPH0587504B2 (ja) | ||
| US4206232A (en) | Relieving hypertension with carboxyalkylacylamino acids | |
| US4620012A (en) | Spirocyclic aminoacid derivatives, processes for their preparation, agents containing them and their use and new spirocyclic aminoacids as intermediates and processes for their preparation | |
| DE3227055A1 (de) | Neue derivate der 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure, verfahren zu ihrer herstellung, diese enthaltende mittel und deren verwendung sowie 2-aza-bicyclo(2.2.2)octan-3-carbonsaeure als zwischenstufe und verfahren zu deren herstellung | |
| JPH0531544B2 (ja) | ||
| US4154937A (en) | Hydroxycarbamoylalkylacylpipecolic acid compounds | |
| KR910001438B1 (ko) | êŽíì íì± ë¹ìíŽëŠ ìŽë¯žë ž-α-칎복ì€ì° ìì€í 륎 ëŒìžë¯žì²Žì ë¶í ë°©ë² | |
| US4921941A (en) | Orally active antiandrogens | |
| JPH01128997A (ja) | ã¢ããé žãšã¹ãã«åã³ãã®è£œé æ¹æ³ | |
| US4920144A (en) | Derivatives of bicyclic amino acids, agents containing them and their use as hypotensives | |
| US5175306A (en) | Process for the resolution of racemates of optically active bicyclic imino-α-carboxylic esters | |
| CA1227212A (en) | Derivatives of cis, endo-2-azabicyclo[5.3.0] decane-3-carboxylic acid, a process for their preparation, agents containing these derivatives and their use | |
| KR880001007B1 (ko) | ë¹ì¬ìŽíŽëŠ íí©ë¬Œì ì ì¡° ë°©ë² | |
| NO157138B (no) | Cis, endo-2-azabiscyklo-(3.3.0)-oktan-3-karboksylsyreestere som er mellomprodukter ved fremstillingen av farmakologisk virksomme angiotensin-convertering-enzyminhibitorer, samt fremgangsmaate til deres fremstilling. |